ZA861052B - Cl-1577-b4 compound,its production and use - Google Patents

Cl-1577-b4 compound,its production and use

Info

Publication number
ZA861052B
ZA861052B ZA861052A ZA861052A ZA861052B ZA 861052 B ZA861052 B ZA 861052B ZA 861052 A ZA861052 A ZA 861052A ZA 861052 A ZA861052 A ZA 861052A ZA 861052 B ZA861052 B ZA 861052B
Authority
ZA
South Africa
Prior art keywords
compound
activity against
gram
sub
cell line
Prior art date
Application number
ZA861052A
Other languages
English (en)
Inventor
John H Wilton
Gerard C Hokanson
James C French
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA861052B publication Critical patent/ZA861052B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA861052A 1985-03-15 1986-02-12 Cl-1577-b4 compound,its production and use ZA861052B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/712,294 US4594248A (en) 1985-03-15 1985-03-15 CL-1577-B4 compound, its production and use

Publications (1)

Publication Number Publication Date
ZA861052B true ZA861052B (en) 1987-09-30

Family

ID=24861526

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA861052A ZA861052B (en) 1985-03-15 1986-02-12 Cl-1577-b4 compound,its production and use

Country Status (10)

Country Link
US (2) US4594248A (de)
EP (1) EP0194784B1 (de)
JP (1) JPH0689012B2 (de)
AT (1) ATE72565T1 (de)
AU (1) AU589943B2 (de)
CA (1) CA1253820A (de)
DE (1) DE3683860D1 (de)
DK (1) DK116286A (de)
ES (1) ES8706162A1 (de)
ZA (1) ZA861052B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539203A (en) * 1984-11-13 1985-09-03 Warner-Lambert Company CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use
US4921700A (en) * 1985-08-27 1990-05-01 Bristol-Myers Company BBM-1675c and d antitumor antibiotics
US4939244A (en) * 1987-01-30 1990-07-03 American Cyanamid Company Pseudoaglycones of LL-E33288 antibiotics
US4837206A (en) * 1987-04-29 1989-06-06 Bristol-Myers Company Esperamicin derivatives
US4916065A (en) * 1988-06-10 1990-04-10 Bristol-Myers Company BU-3420T Antitumor antibiotic
US4952572A (en) * 1988-06-10 1990-08-28 Bristol-Myers Company BU-3420T antifungal antibiotic
US5028536A (en) * 1989-03-15 1991-07-02 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41339
US5086045A (en) * 1989-03-15 1992-02-04 Bristol-Myers Squibb Company Antitumor antibiotic
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335108A (en) * 1980-08-25 1982-06-15 The Upjohn Company Paulomycin A and B and preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4539203A (en) * 1984-11-13 1985-09-03 Warner-Lambert Company CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use

Also Published As

Publication number Publication date
DK116286D0 (da) 1986-03-13
EP0194784B1 (de) 1992-02-12
US4661353A (en) 1987-04-28
ES553051A0 (es) 1987-05-16
DE3683860D1 (de) 1992-03-26
ATE72565T1 (de) 1992-02-15
EP0194784A2 (de) 1986-09-17
AU589943B2 (en) 1989-10-26
JPS61216692A (ja) 1986-09-26
EP0194784A3 (en) 1987-12-09
US4594248A (en) 1986-06-10
JPH0689012B2 (ja) 1994-11-09
CA1253820A (en) 1989-05-09
DK116286A (da) 1986-09-16
AU5337386A (en) 1986-09-18
ES8706162A1 (es) 1987-05-16

Similar Documents

Publication Publication Date Title
DE3479661D1 (en) Antibiotic/antitumor compounds and their production
EP0194784A3 (en) Cl-1577-b4 compound, its production and use
EP0315147A3 (de) Antibiotika, Benanomicine A und B und Dexylosylbenanomicin B, ihre Herstellung und Verwendung
AU584136B2 (en) CL-1577D and 1577E antibiotic/antitumor compounds, their production and use
EP1211259A4 (de) Antibiotische caprazamycine und verfahren zu deren herstellung
DE3574382D1 (en) Micromonospora microorganisms and macrolide antibiotic production therewith
EP0139553A3 (de) 1N-(omega-Amino-alpha-hydroxyalkanoyl)-2',3'-Dideoxykanamycin-A und Herstellung dieses Produktes
EP0139457A3 (de) Antibiotische Verbindung und ihre Herstellung
ES8400489A1 (es) Un metodo para la preparacion de 2-hidroxi-aclacinomicinas a, b y n.
EP0199591A3 (en) Valiolamine derivatives and production thereof
ATE48843T1 (de) 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung.
ES8102188A1 (es) Procedimiento para la obtencion de derivados de la rifamici-na-s
ES8403907A1 (es) Un procedimiento para la produccion de nuevos derivados de los antibio-oa-6129, ca-6129 b1 y ca-6129b2
EG17338A (en) Novel 3-azinomethyl rifamycins
IE860279L (en) (oxy) difficol from b. subtilis
ES8704934A1 (es) Un procedimiento para producir un compuesto analogo a estreptonigrina
GB1387769A (en) Butenoic acid derivatives and a process for the manufacture thereof
CA2158482A1 (en) UCF1 Compounds, Derivatives Thereof and Processes for Their Preparation